Browse Studies — Arctuva

Phase 2

A Multi-Institutional Central Pathology and Molecular Risk-Based Stratification Study of Surgical Management for Melanoma, Atypical Spitz/Spitzoid Tumors, and Other Atypical Melanocytic Neoplasms in Pediatric Patients

This phase II trial compares the effect of using risk-based stratification to guide surgical management to the usual approach in treating cutaneous melanoma, a…

Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8+4 more

Estimated

~$10 – $7,500

Children's Oncology GroupNCT07621614

The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patien…

Adrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm+15 more

Estimated

~$10 – $1,125

Children's Oncology GroupNCT02402244

Prospective Registry of Patients With Neurocutaneous Melanocytosis (NCM) Including Cutaneous and CNS Involvement

This study will involve collecting information about the regular medical care you receive for large cutaneous melanocytic nevi (LCMN) or neurocutaneous melanoc…

Cutaneous Melanocytic NeoplasmLarge Cutaneous Melanocytic NeviNeurocutaneous Melanocytosis

Estimated

~$10 – $750

Memorial Sloan Kettering Cancer CenterNCT04548817